Seer to Report First Quarter 2023 Financial Results on May 9, 2023
April 20 2023 - 4:05PM
Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing
a disruptive new platform for proteomics, today announced that it
will report financial results for the first quarter of 2023 after
market close on Tuesday, May 9, 2023. Company management will be
webcasting a conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
Live audio of the webcast will be available on
the Investor section of Seer’s website at investor.seer.bio. An
archived replay will be available on the company’s website
following the event.
About SeerSeer™ is a life sciences company
developing transformative products that open a new gateway to the
proteome. Seer’s Proteograph™ Product Suite is an integrated
solution that includes proprietary engineered nanoparticles,
consumables, automation instrumentation and software to perform
deep, unbiased proteomic analysis at scale in a matter of hours.
Seer designed the Proteograph workflow to be efficient and easy to
use, leveraging widely adopted laboratory instrumentation to
provide a decentralized solution that can be incorporated by nearly
any lab. Seer’s Proteograph Product Suite is for research use only
and is not intended for diagnostic procedures. For more
information, please visit www.seer.bio.
Investor ContactCarrie
Mendivilinvestor@seer.bio
Media ContactKaren Possematopr@seer.bio
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jun 2024 to Jul 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Jul 2023 to Jul 2024